Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction

Clinical Trial ID NCT01374321

PubWeight™ 10.25^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01374321

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Myocardial ischemia-reperfusion injury: a neglected therapeutic target.	J Clin Invest	2013	2.83
2	Mitochondria as a drug target in ischemic heart disease and cardiomyopathy.	Circ Res	2012	1.31
3	The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective Strategies.	Oxid Med Cell Longev	2016	0.83
4	Novel targets for mitochondrial medicine.	Sci Transl Med	2016	0.82
5	Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial.	J Transl Med	2014	0.81
6	Adjuvant cardioprotection in cardiac surgery: update.	Biomed Res Int	2014	0.81
7	Mitochondrial Regulation of the Muscle Microenvironment in Critical Limb Ischemia.	Front Physiol	2015	0.79
8	Conditioning the heart to prevent myocardial reperfusion injury during PPCI.	Eur Heart J Acute Cardiovasc Care	2012	0.78
9	A new automatic algorithm for quantification of myocardial infarction imaged by late gadolinium enhancement cardiovascular magnetic resonance: experimental validation and comparison to expert delineations in multi-center, multi-vendor patient data.	J Cardiovasc Magn Reson	2016	0.76
10	Extent of Myocardium at Risk for Left Anterior Descending Artery, Right Coronary Artery, and Left Circumflex Artery Occlusion Depicted by Contrast-Enhanced Steady State Free Precession and T2-Weighted Short Tau Inversion Recovery Magnetic Resonance Imaging.	Circ Cardiovasc Imaging	2016	0.75
11	Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT.	BMC Med Imaging	2016	0.75